IC Directors’ Meeting Highlights — February 27, 2014


Dr. Collins provided summaries of several Congressional visits, meetings, and hearings. An overview of recent antimicrobial resistance (AMR) activities, including the NIH-FDA Leadership Council also was described.  

Sub-IC BRAIN Group: Kathy Hudson

Dr. Hudson (DDSOP) described the composition of the Sub-IC BRAIN group and the steps going forward.

Potential Common Fund (CF) Topics: Jim Anderson

Dr. Anderson (DPCPSI) presented a summary of four potential Common Fund topics for consideration, including glycoscience. The discussion focused on particular scientific aspects of each topic, concerns, and integration across the ICs.

This page last reviewed on August 6, 2015